Major Depressive Disorder (MDD)
Showing 1 - 25 of >10,000
Major Depressive Disorder With Anhedonia and Inadequate Response
Not yet recruiting
- Depressive Disorder, Major
- No Intervention
- (no location specified)
Apr 24, 2023
Depression, Depressive Disorder, Depressive Symptoms Trial (TNX-601 ER, Placebo)
Not yet recruiting
- Depression
- +5 more
- TNX-601 ER
- Placebo
- (no location specified)
Jan 6, 2023
Accexible as a Tool for Screening and Monitoring Depression.
Recruiting
- Major Depressive Disorder (MDD)
- Accexible
-
Barcelona, SpainVall d'Hebron Institut de Investigación (VHIR)
Sep 18, 2023
MDD Trial in Columbia (TMS treatment)
Completed
- MDD
- TMS treatment
-
Columbia, MissouriUniversity of Missouri Neuromodulation Center
Dec 8, 2022
MDD Trial in Boston (Smartphone-delivered CBT for MDD)
Not yet recruiting
- Major Depressive Disorder
- Smartphone-delivered CBT for MDD
-
Boston, MassachusettsMassachusetts General Hospital
Oct 3, 2022
MDD, Generalized Anxiety Disorder Trial in New York (HPDT-DA-013)
Recruiting
- Major Depressive Disorder
- Generalized Anxiety Disorder
- HPDT-DA-013
-
New York, New YorkHappify Health (Remote)
Aug 5, 2022
Moderate or Severe Major Depressive Disorder Requiring Urgent
Not yet recruiting
- Depressive Disorder, Major
-
Manchester, United KingdomGreater Manchester Mental Health NHSFT
Jan 31, 2023
Retrospective TMS Therapy for Adults With MDD
Completed
- Major Depressive Disorder (MDD)
- TMS
- (no location specified)
Sep 12, 2022
MDD Trial in New York (Empagliflozin)
Not yet recruiting
- Major Depressive Disorder
-
New York, New YorkNYU Langone Health
Feb 24, 2023
MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)
Not yet recruiting
- Major Depressive Disorder (MDD)
- HS-10353 30mg oral capsules
- +3 more
- (no location specified)
Jul 10, 2023
Depression, Anhedonia Trial in Belmont (Active RS-EFP, Sham RS-EFP)
Not yet recruiting
- Depression
- Anhedonia
- Active RS-EFP
- Sham RS-EFP
-
Belmont, MassachusettsMcLean Hospital
May 17, 2023
MDD Trial in Los Angeles (Placebo, intermittent theta burst stimulation, intravenous citalopram HCl (CIT))
Active, not recruiting
- Major Depressive Disorder
- Placebo
- +3 more
-
Los Angeles, CaliforniaUCLA Depression Research and Clinic Program
May 17, 2022
Constructs and Neural-Behavioral Mechanisms in Older Depression
Not yet recruiting
- Major Depressive Disorder (MDD)
- Healthy Adult Volunteer
- Hot Cognitive Task
- +3 more
- (no location specified)
Aug 1, 2023
MDD (MDD) Trial (Ammoxetine, Placebo)
Not yet recruiting
- Major Depressive Disorder (MDD)
- Ammoxetine
- Placebo
- (no location specified)
Feb 28, 2023
MDD, Chronic Pain Trial in Los Angeles (Active rTMS/Active iTBS DFPLC/Sham Pain M1, Sham rTMS/ Active iTBS Pain, Active
Not yet recruiting
- Major Depressive Disorder
- Chronic Pain
- Active rTMS/Active iTBS DFPLC/Sham Pain M1
- +2 more
-
Los Angeles, CaliforniaUCLA Semel Institute
Oct 11, 2022
Depression, MDD, Mild Depression Trial in Abbotsford (Psilocybin)
Not yet recruiting
- Depression
- +4 more
-
Abbotsford, British Columbia, CanadaCentre for Neurology Studies x Upstream
Oct 25, 2022
MDD Trial in Jackson (ALTO-100 PO Tablet)
Active, not recruiting
- Major Depressive Disorder
- ALTO-100 PO Tablet
-
Coral Gables, Florida
- +1 more
Oct 21, 2022
MDD (MDD) Trial in Long Beach (CTC-501)
Active, not recruiting
- Major Depressive Disorder (MDD)
-
Long Beach, CaliforniaCollaborative Neuroscience Network
Apr 22, 2022
MDD, MDD, Recurrent Episode, Severe, MDD, Recurrent, Moderate Trial in Minnetonka (NeuroStar TMS)
Completed
- Major Depressive Disorder
- +2 more
- NeuroStar TMS
-
Minnetonka, MinnesotaSonder Behavioral Health and Wellness
Nov 3, 2023
MDD (MDD) Trial (Aripiprazole, Escitalopram)
Terminated
- Major Depressive Disorder (MDD)
- (no location specified)
Nov 24, 2021
MDD Trial in Israel, United States (Relivion®DP- Active, Relivion®DP- Sham)
Recruiting
- MDD
- Relivion®DP- Active
- Relivion®DP- Sham
-
La Jolla, California
- +13 more
Jan 12, 2023